REFERENCE
Abbott Laboratories.Abbott and Government of Brazil Sign Kaletra (Rm) (lopinavir/ritonavir) Supply Agreement. Media Release: 4 Jul 2007. Available from: URL: http://www.abbott.com
Rights and permissions
About this article
Cite this article
Abbott's offer to supply lopinavir/ritonavir [Kaletra] at a per-patient cost of $US1000/year has been accepted by the Brazilian government.. Pharmacoecon. Outcomes News 532, 10 (2007). https://doi.org/10.2165/00151234-200705320-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705320-00027